Nano Miscellaneous
Market Cap
₹168 ₹168 Cr.
P/E
0.00
PEG = P/E ÷ 5yr forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.58
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
6.90 %
Institutions
Institutions
0.04 %
Market cap
Market cap
168 Cr
No. of Shareholders
No. of Shareholders
2,929
OPM (%)
OPM (%)
-25.79 %
PE
PE
-
Prom Holding
Prom Holding
-
ROCE (%)
ROCE (%)
5.59
ROE (%)
ROE (%)
4.35
Sales
Sales
86.26 Cr
  • Vaxfab Enterprise
  • Positron Energy
  • Brand Concepts
Last updated on 1 Oct 2026
  • Vaxfab Enterprises, formerly Ellora Trading Limited, is a trading company with one reported segment, trading of goods. The standalone business trades textiles. Consolidated FY26 revenue was ~₹131Cr, nearly double FY25.
  • It pivoted to trading in FY23, when standalone revenue went from ₹0.27Cr in the prior year to ₹16.75Cr.
  • Reported profit depends on other income and fair-value changes on investments. The group adds two subsidiaries and an associate, so standalone and consolidated earnings diverge.
  • The stated growth leg is a new UAE trading subsidiary, licensed for seeds, packaging and general trading. It has not started operations.
  • Q1FY27 broke the recovery: operating revenue was ₹0.40Cr against ₹14.57Cr in Q1FY26. Management attributes the ₹5.84Cr standalone loss to a notional fair-value loss on investments.
  • Trading growth has not produced cash. FY26 standalone receivables were ₹106.9Cr and payables ₹110.9Cr, against only ₹2.1Cr of cash.
  • Capital actions stay dilution-heavy: three 2026 warrant tranches and a ₹45Cr rights issue. Paid-up equity of ₹25.83Cr is unreconciled with ₹40.09Cr in FY26 balance-sheet data.
  • Near-term earnings depend on whether trading revenue returns after the near-zero first quarter.
  • Audits remain impaired: reviews again flagged missing prior-period records and confirmations, and FY26 auditors disclaimed the consolidated opinion.
  • Revenue recovery after near-zero Q1 ~mid-November 2026
    the print settles whether trading revenue returns from ₹0.40Cr and whether paid-up capital reconciles with FY26 data.
  • Remaining warrant conversions by July 2027
    each conversion adds shares at ₹21.02, and the final count must reconcile paid-up capital of ₹25.83Cr with the ₹40.09Cr filed for FY26.
  • Rights issue up to ₹45Cr no stated timeline
    price, ratio and record date are undecided. The terms will set dilution on top of ₹25.83Cr paid-up capital.
  • UAE subsidiary starts operations no stated timeline
    the unit had no turnover at incorporation. Its first operating update shows whether the broad license becomes a new business line.
  • Audit remediation no stated timeline
    the next reviews repeat the same qualifications unless missing records, confirmations and expected-credit-loss workings are rebuilt.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
33
52W Range
High
72
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Vaxfab Enterprises Ltd. Business

Vaxfab Enterprises Limited, formerly known as Ellora Trading Limited, is a company incorporated in 1983 in Ahmedabad, Gujarat. They are engaged in the trading of fabrics and garments.

Vaxfab Enterprise major competitors are Positron Energy, Metroglobal, AVI Polymers, Swadeshi Inds.&Leas., Amrapali Industries, Brand Concepts, Rama Vision.
Market Cap of Vaxfab Enterprise is ₹170 Crs.
While the median market cap of its peers are ₹176 Crs.

Vaxfab Enterprise seems to be less financially stable compared to its competitors.
Altman Z score of Vaxfab Enterprise is 0.53 and is ranked 8 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Dec
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material